This issue's highlights are:
- Science: KRISP has produced most of the COVID-19 viral genomes in South Africa
- News: KRISP Scientific News coverage in over 30 newspapers and TVs.
- The Guardian: There is no magic bullet: the town that turned the tide against HIV. Lessons learned in Eshowe are being used against coronavirus.
- Publication: Migration and maternal mortality among HIV-positive postpartum women: A population-based longitudinal study.
- Publication: New Genomes from The Congo Basin Expand History of CRF01_AE Origin and Dissemination
- Publications: Priorities among HIV-positive individuals for tuberculosis preventive therapies
- Publications: Current Affairs of Microbial Genome-Wide Association Studies: Approaches, Bottlenecks and Analytical Pitfalls
- Fundraising: Support South Africa's COVID-19 Scientists on the Frontline
The concept behind this newsletter is that anyone with 15 minutes to spare can learn about the work of the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), which is a Platform of the Technology Innovation Agency (TIA) at University of KwaZulu-Natal (UKZN), Durban, South Africa.
KRISP wants to want to challenge the status quo and create a scientific environment in South Africa that drives innovations in global health and reverses the brain drain. A critical function of KRISP will be to make genomics, epigenetics and bioinformatics accessible to academic, industrial and commercial users.
News date: 2020-05-05
Links:
http://www.krisp.org.za/manuscripts/KRISPnewsletter_4_2020.pdf
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira